New nerve pain drug passes first safety check in humans
Symptom relief
Completed
This early-stage study tested a single dose of a new drug called 4ET1103 in 40 healthy volunteers to see if it is safe and how the body processes it. Half received the drug, half a placebo, and all were monitored for side effects and changes in blood, urine, and vital signs. The …
Phase: PHASE1 • Sponsor: 4E Therapeutics • Aim: Symptom relief
Last updated May 17, 2026 03:38 UTC